For the Quarter Ending September 2025
North America
• In USA, the Vitamin B9 Price Index rose by 8% quarter-over-quarter, supported by nutraceutical demand.
• The average Vitamin B9 price for the quarter was approximately USD 58233.33/MT reflecting steady demand.
• Vitamin B9 Spot Price remained supported by balanced inventories and measured restocking from formulators recently.
• Vitamin B9 Price Forecast indicates gradual Q4 gains driven by seasonal procurement and export replenishment.
• Vitamin B9 Production Cost Trend remained soft due to ample feedstock and steady intermediate availability.
• Vitamin B9 Demand Outlook remains steady with prenatal, fortified-food and personal care sectors providing offtake.
• Vitamin B9 Price Index weakened in September as inventories accumulated and exporters competed aggressively internationally.
• Major US producers operated reliably with consistent output, supporting continuous shipments and tempering market volatility.
Why did the price of Vitamin B9 change in September 2025 in North America?
• Inventory overhang across domestic and export channels reduced procurement urgency, pressuring quotations during late September.
• Substitution toward methylfolate in premium prenatal formulations diverted volumes from conventional Vitamin B9, weakening demand.
• Ample feedstock and US production kept input costs stable, allowing exporters to adjust offers downward.
APAC
• In China, the Vitamin B9 Price Index rose by 1.26% quarter-over-quarter, reflecting modest restocking activity.
• The average Vitamin B9 price for the quarter was approximately USD 45906.67/MT, per Qingdao assessments.
• Vitamin B9 Spot Price remained firm this quarter, supported by steady export inquiries and restocking.
• Vitamin B9 Price Forecast suggests upward bias as buyers rebuild seasonal inventories ahead of winter.
• Vitamin B9 Production Cost Trend stayed stable, supported by uninterrupted feedstocks and steady energy tariffs.
• Vitamin B9 Demand Outlook remains steady with pharmaceutical and nutraceutical procurement disciplined, limiting speculative buying.
• Vitamin B9 Price Index declined in September due to downstream destocking and holiday buying pauses.
• Producers trimmed run-rates and idled lines to rebalance stocks, intermittently tightening spot availability for buyers.
Why did the price of Vitamin B9 change in September 2025 in APAC?
• Uninterrupted feedstock and stable energy tariffs contained production costs, limiting upward price pressure in September.
• Downstream destocking and Golden Week pauses reduced export inquiries, weakening September spot pricing in APAC.
• Exporters trimmed offers amid subdued international demand, while selective line idlings aided inventory rebalancing efforts.
Europe
• In Germany, the Vitamin B9 Price Index rose by 1.26% quarter-over-quarter, driven by downstream restocking.
• The average Vitamin B9 price for the quarter was approximately USD 46012.00/MT for German imports.
• Vitamin B9 Spot Price stayed range-bound with weekly declines, reflecting balanced supply-demand and cautious buying.
• Vitamin B9 Price Forecast indicates modest recovery as scheduled procurement resumes, providing limited upward pressure.
• Vitamin B9 Production Cost Trend muted due to ample feedstock availability, restraining upstream cost pressures.
• Vitamin B9 Demand Outlook remains steady with prenatal and nutraceutical procurement predictable, supporting measured buying.
• Inventory accumulation moderated spot bids, while softer export offers weighed on the Vitamin B9 Price Index.
• Export production remained uninterrupted; ports operated smoothly, preserving flows and constraining volatility in Vitamin B9 Spot Price.
Why did the price of Vitamin B9 change in September 2025 in Europe?
• Downstream inventory surplus reduced immediate procurement urgency, causing downward pressure on September import Price Index.
• Export offers softened with origin production intact, translating into lower costs and softer import prices.
• Logistics operated smoothly, enabling on-time deliveries, preventing cost spikes but failing to stimulate urgent buying.
For the Quarter Ending June 2025
North America
• The Vitamin B9 Spot Price in North America climbed steadily throughout Q2 which was supported by heightened Q2 procurement among fortified food and nutraceutical manufacturers.
• The Price Index closed at USD 58,200/MT FOB New Jersey by the end of June that reflected robust market confidence and a tightening spot availability environment.
• In April, a 1% rise was attributed to advanced restocking by formulators aligning their Q2 cycles with forecasted Q3 supplement launches.
• May experienced a 1.89% uptick as manufacturers have reacted to supplier advisories suggesting constrained availability during the early summer.
• June saw a more accelerated 3.9% increase driven by institutional purchases and demand contracts from OTC pharmaceutical producers seeking inventory security.
• The Vitamin B9 Demand Outlook remained strong, particularly in prenatal and general wellness supplements, sustaining purchasing momentum through Q2.
• The Vitamin B9 Production Cost Trend was broadly stable due to consistent input prices and predictable domestic energy and labor costs.
• Buyers across North America maintained structured procurement plans, limiting price volatility by balancing proactive restocking with predictable formulation cycles.
• Why did the price change in July 2025?
Prices softened marginally in July, as Q2 bulk purchases had already secured near-term requirements, leading to a temporary reduction in active restocking activity across pharmaceutical and supplement formulators.
Asia Pacific
• The Vitamin B9 Spot Price in the APAC region remained stable to firm across Q2, underpinned by consistent regional demand and proactive procurement by bulk buyers.
• The Price Index was recorded at USD 46,500/MT FOB Qingdao by June, reflecting well-balanced trading fundamentals and controlled export flows.
• April registered a 5.10% price rise, driven by accelerated restocking from Southeast Asian and South Asian importers preparing for Q3 public health initiatives.
• May and June each observed a 0.22% month-on-month increase, as suppliers maintained export parity pricing and buyers kept order volumes regular.
• The Vitamin B9 Demand Outlook remained firm due to stable consumption by multivitamin premix companies and institutional nutrition programs across Asia and the Middle East.
• The Vitamin B9 Production Cost Trend remained favorable, aided by steady feedstock availability, unimpeded throughput, and high factory utilization rates in China.
• Exporters maintained well-spaced contract delivery schedules, reducing pricing pressures and ensuring a controlled flow into regional ports.
• APAC buyers demonstrated caution in exceeding replenishment targets, contributing to a flattened pricing trajectory by end-Q2.
• Why did the price change in July 2025?
Prices held steady in July as regional buyers delayed new purchases, given sufficient carryover inventories from Q2 and the absence of immediate Q3 demand triggers.
Europe
• The Vitamin B9 Spot Price in Europe moved gradually upward across Q2, with importers responding to localized supply risk and modest global firming.
• The Price Index reached USD 46,620/MT CFR Hamburg by June, signalling a stable yet slightly firm market supported by cautious stockpiling.
• April saw a 5.04% price increase as regional buyers anticipated stronger Q3 food supplement sales and front-loaded procurement accordingly.
• May posted a restrained 0.22% increase, as distributors synchronized local pricing with international offer levels without pushing excess volume.
• Another 0.21% gain in June was recorded as producers finalized end-of-quarter inventory adjustments, avoiding oversupply.
• The Vitamin B9 Demand Outlook remained consistent throughout Q3 which was driven by the fortified breakfast foods, prenatal nutrition and over-the-counter health categories.
• The Vitamin B9 Production Cost Trend remained moderate, supported by manageable intra-EU logistics and stable CIF valuations from origin markets.
• Buyers in Western and Central Europe employed phased inventory strategies to prevent oversupply while maintaining readiness for Q3 consumer demand.
• Why did the price change in July 2025?
Prices flattened or slightly corrected in July as European buyers paused procurement activity to draw down Q2 inventories, with limited urgency for early Q3 acquisitions.
For the Quarter Ending March 2025
North America
The Vitamin B9 market in North America posted a steady price increase in the first quarter of 2025, with average prices rising by around 12.66% compared to the previous quarter. This upward shift started in December due to higher winter demand for folic acid supplements and carried forward into the new year. Limited stock availability from late 2024 created a need for aggressive procurement as the quarter opened.
Buyers not only placed fresh orders to support ongoing production cycles but also moved to build extra inventory to guard against any possible supply delays. Seasonal transition from winter to spring also had an impact on immediate consumption trends and the demand from pharmaceuticals and nutraceuticals sectors remained consistent and healthy.
Meanwhile, food and beverage manufacturers secured stocks based on routine production schedules. Tariff adjustments on certain pharmaceutical components added a layer of uncertainty. This pushed some Vitamin B9 suppliers and distributors to firm up supply agreements early. Overall, the Vitamin B9 market stayed active, with both supplement and pharmaceutical demand contributing to this price rise in the first quarter of 2025.
Asia Pacific
The Asia Pacific Vitamin B9 market witnessed a sharp price increase during the first quarter of 2025, with an average rise of about 45.26% from the previous quarter. The price rally that began in December continued well into March. This increase in Vitamin B9 prices was driven by stock shortages and increased procurement ahead of the Chinese Lunar New Year.
China which is the region’s largest supplier of folic acid experienced a slow production during the holiday period, which tightened availability and raised prices across export markets. Procurement specialists in key APAC countries moved swiftly to secure inventories for immediate and upcoming production cycles. Downstream demand from the pharmaceuticals and nutraceuticals sectors remained firm, whereas the food and beverage manufacturers maintained a need-based procurement approach to sustain routine output.
The seasonal transition from cooler months to spring played a supporting role, as consumption patterns gradually shifted without a dramatic slowdown. The Vitamin B9 market in Asia Pacific remained buoyant throughout the first quarter of 2025, with Vitamin B9 suppliers and distributors reporting sustained orders and firm pricing trends.
Europe
The Vitamin B9 market in Europe registered a noticeable price increase in the first quarter of 2025, averaging a 30.32% rise compared to the concluding quarter of 2024. The surge was largely a result of tightening availability stemming from higher winter consumption and reduced inventory positions as the year began. Buyers moved quickly in January to cover production requirements and rebuild safety stocks which led to increased procurement activity.
Pharmaceuticals and nutraceuticals sectors due to increase in the end-user demand led to higher price trends of Vitamin B9, while food and beverage manufacturers placed requirement-based orders to ensure uninterrupted production. The seasonal shift from colder months to spring brought slight changes in consumption behaviour, but overall downstream demand remained stable.
Additionally, the firmness in prices of Folic Acid from Asia Pacific markets indirectly supported European price movements, as global Vitamin B9 market sentiment leaned positive. By the end of first quarter of 2025, Vitamin B9 suppliers and distributors reported steady enquiries and firm negotiations and was reflected in the sustained market activity throughout the quarter.
For the Quarter Ending December 2024
North America
During the quarter 4 of 2024, Vitamin B9 prices in North America displayed a considerable price increase of +5.45% across the entire quarter. Values rose from $43,150 per MT in October to $45,500 per MT FOB New Jersey in December 2024, exhibiting a positive momentum during the quarter. The price dynamics emerged from several market factors. Enhanced and sustained demand from downstream pharmaceutical and nutraceutical industries supported higher prices throughout the quarter.
Port infrastructure improvements and reduced logistics constraints supported price appreciation. Market participants maintained high TEU volumes, with December bringing further market momentum as domestic suppliers implemented strategic pricing initiatives amid inventory handling. Export prices firmed up in the US market.
The market followed robust seasonal trends as the year 2024 concluded. Sustained end-user demand persisted throughout the quarter, especially in pharmaceutical and nutraceutical applications. This combination created a complex environment where supply chain stabilization and increasing demand drove prices higher.
APAC
In Q4 2024, Vitamin B9 prices in APAC demonstrated remarkable market dynamics, experiencing a substantial price increase of around 49% from $22,690 per MT in October to $33,770 per MT FOB Shanghai in December 2024. The quarter was characterized by complex market interactions, beginning with the Chinese Golden Week holiday, which initially paused market activities but subsequently triggered strategic procurement approaches.
Manufacturers capitalized on limited inventories, improving freight rates and escalating demand from Western markets. The region witnessed sophisticated supply chain strategies, with companies implementing nuanced inventory management techniques. International buyers displayed proactive procurement behaviours, compelling Chinese manufacturers and suppliers to strategically ramp up production and adjust pricing strategies in response to escalating global demand.
December marked a pivotal transformation, with systematic inventory expansion and suppliers strategically positioning themselves for emerging market opportunities. Demand fundamentals remained exceptionally robust, characterized by sustained and diversified procurement patterns across domestic and international channels. The price trajectory reflected the APAC region's adaptive and responsive market ecosystem, creating unique market engagement opportunities for stakeholders.
Europe
In Q4 2024, Vitamin B9 import prices in Germany demonstrated a significant upward trajectory, rising by more than 31% from $28,080 per MT in November to $37,000 per MT CFR Hamburg in December. The quarter was distinguished by complex market dynamics, driven by surging demand, extended delivery timelines from Asian suppliers, and increasingly favourable market conditions.
November witnessed continued price appreciation, propelled by robust global end-user demand that compelled German buyers to procure at progressively higher costs. The constrained market environment empowered merchants to implement strategic price increases, maintaining substantially stronger profit margins compared to previous periods.
December brought further price escalation, characterized by European distributors' aggressive pursuit of additional supplies and international exporters maintaining competitive pricing strategies. The market environment demonstrated remarkable resilience, with sophisticated supply chain interactions creating a dynamic, growth-oriented landscape that balanced complex procurement challenges with strategic market opportunities.
